International Journal of Radiation Oncology * Biology * Physics
Volume 62, Issue 2 , Pages 309-317, 1 June 2005

Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: A report from the Radiation Therapy Oncology Group

  • Arnab Chakravarti, M.D.

      Affiliations

    • Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA
    • Corresponding Author InformationReprint requests to: Arnab Chakravarti, M.D., Massachusetts General Hospital, Department of Radiation Oncology, 100 Blossom Street, Founders House, Room 536, Boston, MA 02114. Tel: (617) 724-1175; Fax: (617) 726-2098
    • ,
  • Kathryn Winter, M.S.

      Affiliations

    • Department of Biostatistics, Radiation Therapy Oncology Group, LDS Hospital, Salt Lake City, UT
    • ,
  • Chin-Lee Wu, M.D., Ph.D.

      Affiliations

    • Department of Pathology, Massachusetts General Hospital, Boston, MA
    • ,
  • Donald Kaufman, M.D.

      Affiliations

    • Department of Medical Oncology, Massachusetts General Hospital, Boston, MA
    • ,
  • Elizabeth Hammond, M.D.

      Affiliations

    • Department of Pathology, LDS Hospital, Salt Lake City, UT
    • ,
  • Matthew Parliament, M.D.

      Affiliations

    • Department of Radiation Oncology, Cross Center Institute, Edmonton, Alberta, Canada
    • ,
  • William Tester, M.D.

      Affiliations

    • Department of Radiation Oncology, Albert Einstein Cancer Center, Philadelphia, PA
    • ,
  • Michael Hagan, M.D.

      Affiliations

    • Department of Radiation Oncology, Medical College of Virginia, Richmond, VA
    • ,
  • David Grignon, M.D.

      Affiliations

    • Department of Pathology, Harper Hospital, Detroit, MI
    • ,
  • Niall Heney, M.D.

      Affiliations

    • Department of Urology, Massachusetts General Hospital, Boston, MA
    • ,
  • Alan Pollack, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA
    • ,
  • Howard Sandler, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Michigan, Ann Arbor, MI
    • ,
  • William Shipley, M.D.

      Affiliations

    • Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA

Received 15 April 2004; received in revised form 13 September 2004; accepted 16 September 2004. published online 02 February 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This study was supported by RTOG U10 CA21661, CCOP U10 CA37422, and Stat U10 CA32115 grants from the NCI. The contents of this manuscript are the sole responsibility of the authors and do not necessarily represent the official views of the NCI.

PII: S0360-3016(04)02676-8

doi:10.1016/j.ijrobp.2004.09.047

International Journal of Radiation Oncology * Biology * Physics
Volume 62, Issue 2 , Pages 309-317, 1 June 2005

Article Tools

* Image Usage & Resolution